Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Validity of an Observation Method for Assessing Pain Behavior in Individuals With Multiple Sclerosis.
[Intrathecal immunoglobulin production in the diagnosis and differential diagnosis of multiple sclerosis.]
Botulinum toxin type A and neurogenic urinary incontinence: sometimes beneficial, if used safely.
Amelioration of autoimmune neuroinflammation by the fusion molecule Fn14·TRAIL.
Immune-mediated inflammatory diseases: progress in molecular pathogenesis and therapeutic strategies.
Oculopalatal tremor in multiple sclerosis with spontaneous resolution.
AMP-Activated Protein Kinase Signaling Protects Oligodendrocytes that Restore Central Nervous System Functions in an Experimental Autoimmune Encephalomyelitis Model.
Burden of disease of multiple sclerosis in Korea.
Influence of Personality on the Relationship Between Gray Matter Volume and Neuropsychiatric Symptoms in Multiple Sclerosis.
Impact on health-related quality of life in multiple sclerosis patients due to a managed care program in Colombia.
Abnormally high levels of anti-collagen type IV IgG antibodies in the serum of patients with a clinically isolated syndrome correlate with an increased risk of conversion to MS.
STAT4 controls GM-CSF production by both Th1 and Th17 cells during EAE.
Chronic pain in multiple sclerosis: Is there also fibromyalgia? An observational study.
Microglia as a critical player in both developmental and late-life CNS pathologies.
Psychiatric diagnoses, medication and risk for disability pension in multiple sclerosis patients; a population-based register study.
Multiple sclerosis in Germany: data analysis of administrative prevalence and healthcare delivery in the statutory health system.
Something Old, New, Borrowed, Blue: Anthracenedione Agents for Treatment of Multiple Sclerosis.
Epidemiology of environmental exposures and human autoimmune diseases: Findings from a National Institute of Environmental Health Sciences Expert Panel Workshop.
High in vitro immune reactivity to Escherichia coli in neuromyelitis optica patients is correlated with both neurological disabilities and elevated plasma lipopolysaccharide levels.
Similarities between Inherited Demyelinating Neuropathies and Wallerian Degeneration: An Old Repair Program May Cause Myelin and Axon Perturbation under Nonlesion Conditions.
Comorbidities at multiple sclerosis diagnosis.
Quantifying the local tissue volume and composition in individual brains with magnetic resonance imaging.
Effects of single dose mixed amphetamine salts - extended release on processing speed in multiple sclerosis: a double blind placebo controlled study.
Characterisation of a Novel Anti-CD52 Antibody with Improved Efficacy and Reduced Immunogenicity.
Targeting molecules to medicine with mTOR, autophagy, and neurodegenerative disorders.
Pages
« first
‹ previous
…
439
440
441
442
443
444
445
446
447
…
next ›
last »